These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8439809)
1. Cancer chemotherapeutic and biologic agents. Kennealey GT CA Cancer J Clin; 1993; 43(2):127; author reply 127-8. PubMed ID: 8439809 [No Abstract] [Full Text] [Related]
2. Cancer chemotherapeutic and biologic agents. Sadoff L CA Cancer J Clin; 1993; 43(2):127; author reply 127-8. PubMed ID: 8439810 [No Abstract] [Full Text] [Related]
3. [Other new antineoplastic chemotherapeutic agents]. Motycka K; Beran M Cas Lek Cesk; 1972 Nov; 111(45):1061-2. PubMed ID: 5084856 [No Abstract] [Full Text] [Related]
4. Natural products, both small and large, and a focus on cancer treatment. McAlpine J; Romano A; Ecker D Curr Opin Drug Discov Devel; 2009 Mar; 12(2):186-8. PubMed ID: 19333863 [No Abstract] [Full Text] [Related]
5. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer. Chu E Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405 [No Abstract] [Full Text] [Related]
6. Short term results from GHRH analogue use in pre-menopausal breast cancer in Korea. Kim HJ; Lee JS; Park EH; Lim WS; Sei JY; Koh BS; Son BH; Ahn JH; Jeong KH; Kim SB; Ahn SH Eur J Surg Oncol; 2009 Sep; 35(9):936-41. PubMed ID: 19269125 [TBL] [Abstract][Full Text] [Related]
7. Impact of natural products on developing new anti-cancer agents. Cragg GM; Grothaus PG; Newman DJ Chem Rev; 2009 Jul; 109(7):3012-43. PubMed ID: 19422222 [No Abstract] [Full Text] [Related]
8. Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer. Fujii Y; Yonese J; Kawakami S; Yamamoto S; Okubo Y; Fukui I BJU Int; 2008 May; 101(9):1096-100. PubMed ID: 18190637 [TBL] [Abstract][Full Text] [Related]
9. [New antineoplastic drugs]. DE SOCIO V Rass Int Clin Ter; 1957 Feb; 37(4):148-54. PubMed ID: 13420462 [No Abstract] [Full Text] [Related]
10. Gonadotropin-releasing hormone agonists for the management of ovarian cysts in menopause breast cancer patients on tamoxifen treatment. Kourounis G; Zervoudis S; Michail G; Fotopoulos A Breast J; 2005; 11(5):365-6. PubMed ID: 16174165 [No Abstract] [Full Text] [Related]
11. FDA launches "new use initiative". Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604 [No Abstract] [Full Text] [Related]
12. Sticker shock sharpens focus on biologics. McNeil C J Natl Cancer Inst; 2007 Jun; 99(12):910-2, 914. PubMed ID: 17565148 [No Abstract] [Full Text] [Related]
13. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy. Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065 [TBL] [Abstract][Full Text] [Related]
14. Loading doses for costly cancer biologicals: a cause for concern or tilting at windmills? Hennig IM; Twelves C Eur J Cancer; 2008 Jul; 44(11):1493-6. PubMed ID: 18515087 [TBL] [Abstract][Full Text] [Related]
15. Loading doses for costly cancer biologicals: sound pharmacology or unnecessary extravagance? Epstein RJ; Cheung BM Eur J Cancer; 2008 Jul; 44(11):1488-92. PubMed ID: 18194858 [TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. Gnant MF; Mlineritsch B; Luschin-Ebengreuth G; Grampp S; Kaessmann H; Schmid M; Menzel C; Piswanger-Soelkner JC; Galid A; Mittlboeck M; Hausmaninger H; Jakesz R; J Clin Oncol; 2007 Mar; 25(7):820-8. PubMed ID: 17159195 [TBL] [Abstract][Full Text] [Related]